Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

Stopped early

Conditions studied: Cell-mediated Immune Response

In brief

To compare the performance of the QuantiFERON Monitor assay against existing methodology.

Key facts

Study ID

NCT02416414

Run by

QIAGEN Gaithersburg, Inc

People needed

166

Starts

2015-07-01

Expected to finish

2016-02-01

Last updated by the study team

2016-03-29

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provide Informed Consent
• Received a solid organ transplant

You may not qualify if…

• Pregnancy or recent lactation (<1yr)
• Treatment of Rejection
• Healthy Control
• Inclusion Criteria:
• Provide Informed Consent
• Exclusion Criteria:
• Currently taking any immunomodulatory medication
• A history of immunosuppressive disease or immunosuppression condition or history of autoimmune diseases
• Current pregnancy or recent lactation (<1yr)
• Currently taking antiviral medication
• Currently being treated for infectious diseases

Where it is running

• University of California Los Angeles — Los Angeles, California, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• The Cleveland Clinic Foundation — Cleveland, Ohio, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.